Apeloa is heading to CPHI Milan 2026!
📅 October 6–8, 2026
📍 Fiera Milano, Italy | Booth #7D50
Explore our end-to-end capabilities across our comprehensive business offerings:
• Ability to deliver APIs to support customers’ first‑to‑market product launches, alongside advanced APIs spanning diverse therapeutic areas including cephalosporins, cardiovascular, CNS, immunology, GLP‑1.
• CDMO Services offering integrated DS+DP solutions backed by 11 technology platforms including Flow Chemistry, Peptides, High Potency, and Oligonucleotides
• Finished Dosage Forms (FDF) featuring US FDA-approved products (Metoprolol Succinate ER, Bupropion HCl XL, and Brivaracetam Tabs) and biosimilars from our new ArtiThera Biotech
Connect with us in Milan to discover how our comprehensive pharma solutions can accelerate your projects.
